Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies : post-hoc analysis of a large clinical trial safety database
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Haematologica - (2024) vom: 29. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Brown, Jennifer R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 01.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.3324/haematol.2023.283846 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369161882 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369161882 | ||
| 003 | DE-627 | ||
| 005 | 20240301233456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2023.283846 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM369161882 | ||
| 035 | |a (NLM)38426293 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Brown, Jennifer R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies |b post-hoc analysis of a large clinical trial safety database |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Ghia, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Jurczak, Wojciech |e verfasserin |4 aut | |
| 700 | 1 | |a Kahl, Brad S |e verfasserin |4 aut | |
| 700 | 1 | |a Lamanna, Nicole |e verfasserin |4 aut | |
| 700 | 1 | |a Robak, Tadeusz |e verfasserin |4 aut | |
| 700 | 1 | |a Shadman, Mazyar |e verfasserin |4 aut | |
| 700 | 1 | |a Tam, Constantine S |e verfasserin |4 aut | |
| 700 | 1 | |a Qiu, Lugui |e verfasserin |4 aut | |
| 700 | 1 | |a Paik, Jason |e verfasserin |4 aut | |
| 700 | 1 | |a Salmi, Tommi |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Liping |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Meng |e verfasserin |4 aut | |
| 700 | 1 | |a Cohen, Aileen |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Han |e verfasserin |4 aut | |
| 700 | 1 | |a Tedeschi, Alessandra |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d 1947 |g (2024) vom: 29. Feb. |w (DE-627)NLM000081892 |x 1592-8721 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:29 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3324/haematol.2023.283846 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 29 |c 02 | ||